Director of interventional cardiology at Northern Arizona Healthcare
Does the length of evolocumab use contribute to myocardial infarction associated hospital readmissions in patients with ACS?: a single center real world evidence from ELAINE
Event: ESC Preventive Cardiology 2025
Topic: Prevention
Session: Dyslipidaemia management in 2025: status quo and best practice (1)
